Structure |
Chemical Name |
CAS |
MF |
![(1R,3R,4R)-3-AMino-4-hydroxy-cyclohexanecarboxylic acid ethyl ester](/CAS/20150408/GIF/1392745-70-8.gif) |
(1R,3R,4R)-3-AMino-4-hydroxy-cyclohexanecarboxylic acid ethyl ester |
1392745-70-8 |
C14H25NO5 |
![(S)-3-ヒドロキシピペリジン](/CAS/20150408/GIF/24211-55-0.gif) |
(S)-3-ヒドロキシピペリジン |
24211-55-0 |
C5H11NO |
![EzetiMibe ring-opening dehydrate iMpurity](/CAS/20210111/GIF/1292292-63-7.gif) |
EzetiMibe ring-opening dehydrate iMpurity |
1292292-63-7 |
C24H21F2NO3 |
![Fondaparinux sodiuM iMpurity 1](/CAS/20180808/GIF/348625-84-3.gif) |
Fondaparinux sodiuM iMpurity 1 |
348625-84-3 |
C13H21NO19S3 |
![Pitavastatin IMpurity 4 (PP-4)](/CAS/20200611/GIF/1422058-54-5.gif) |
Pitavastatin IMpurity 4 (PP-4) |
1422058-54-5 |
C25H22FNO3 |
![Pregabalin IMpurity](/CAS/20200611/GIF/159029-27-3.gif) |
Pregabalin IMpurity |
159029-27-3 |
C7H18N2 |
![Valdecoxib 3'-SulfonaMide IMpurity](/CAS/20180906/GIF/1373038-56-2.gif) |
Valdecoxib 3'-SulfonaMide IMpurity |
1373038-56-2 |
C16H14N2O3S |
![(3R,4R)-4-(2,5-Difluorophenyl)-3-Methyl-4-(1H-1,2,4-triazol-1-ylMethyl)-2-oxetanone](/CAS/20150408/GIF/483340-20-1.gif) |
(3R,4R)-4-(2,5-Difluorophenyl)-3-Methyl-4-(1H-1,2,4-triazol-1-ylMethyl)-2-oxetanone |
483340-20-1 |
C13H11F2N3O2 |
![6,7-DiMethoxy-2-(4-(tetrahydrofuran-2-carbonyl)piperazin-1-yl)quinazolin-4(1H)-one](/CAS/20150408/GIF/1177261-73-2.gif) |
6,7-DiMethoxy-2-(4-(tetrahydrofuran-2-carbonyl)piperazin-1-yl)quinazolin-4(1H)-one |
1177261-73-2 |
C19H24N4O5 |
![13-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid](/CAS/20150408/GIF/229312-33-8.gif) |
13-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid |
229312-33-8 |
C13H22N4O5 |
![rac-Clopidogrel Carboxylic Acid Hydrochloride](/CAS/20180808/GIF/1015247-88-7.gif) |
rac-Clopidogrel Carboxylic Acid Hydrochloride |
1015247-88-7 |
C15H15Cl2NO2S |
![Milnacipran IMpurity](/CAS/20210111/GIF/810696-16-3.gif) |
Milnacipran IMpurity |
810696-16-3 |
C11H11NO |
![Terbutaline IMpurity 8](/CAS/20210111/GIF/28924-20-1.gif) |
Terbutaline IMpurity 8 |
28924-20-1 |
C26H30BrNO3 |
![Etoricoxib IMpurity](/CAS/20181212/GIF/1350206-14-2.gif) |
Etoricoxib IMpurity |
1350206-14-2 |
C18H16N2O2S |
![(1R,2R,4S)-2-[(tert-butoxycarbonyl)aMino]-4-[(diMethylaMino)carbonyl]cyclohexyl Methanesulfonate](/CAS/20150408/GIF/929693-31-2.gif) |
(1R,2R,4S)-2-[(tert-butoxycarbonyl)aMino]-4-[(diMethylaMino)carbonyl]cyclohexyl Methanesulfonate |
929693-31-2 |
C15H28N2O6S |
![4-ヒドロキシ-7-メトキシキノリン-6-カルボアミド](/CAS/20150408/GIF/417724-81-3.gif) |
4-ヒドロキシ-7-メトキシキノリン-6-カルボアミド |
417724-81-3 |
C11H10N2O3 |
![Tegafur Impurity BCB](/) |
Tegafur Impurity BCB |
|
|
![((2R,3R,4R)-3-(benzoyloxy)-4-chloro-4-Methyl-5-oxotetrahydrofuran-2-yl)Methyl benzoate](/CAS/20150408/GIF/1496551-65-5.gif) |
((2R,3R,4R)-3-(benzoyloxy)-4-chloro-4-Methyl-5-oxotetrahydrofuran-2-yl)Methyl benzoate |
1496551-65-5 |
C20H17ClO6 |
![2-(4-fluorophenyl)-5-(2-Methylbenzyl)thiophene](/CAS/20150408/GIF/CB12715972.gif) |
2-(4-fluorophenyl)-5-(2-Methylbenzyl)thiophene |
2005454-69-1 |
C18H15FS |
![AcetaMide, N-[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]-](/CAS/20150408/GIF/1429334-00-8.gif) |
AcetaMide, N-[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]- |
1429334-00-8 |
C16H19N3O5 |
![PSI 7411](/CAS/20180808/GIF/1015073-43-4.gif) |
PSI 7411 |
1015073-43-4 |
C10H14FN2O8P |
![5-[[4-(Hydroxymethyl)phenoxy]methyl]-3-(1-methylethyl)-2-oxazolidinone](/CAS/20150408/GIF/1071765-44-0.gif) |
5-[[4-(Hydroxymethyl)phenoxy]methyl]-3-(1-methylethyl)-2-oxazolidinone |
1071765-44-0 |
C14H19NO4 |
![(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol 2,3,4,6-tetrakis(2,2-dimethylpropanoate)](/CAS/20180906/GIF/1283129-18-9.gif) |
(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol 2,3,4,6-tetrakis(2,2-dimethylpropanoate) |
1283129-18-9 |
C44H57FO9S |
![1,4′-ビピペリジン-1′-カルボン酸](/CAS/20150408/GIF/1026078-50-1.gif) |
1,4′-ビピペリジン-1′-カルボン酸 |
1026078-50-1 |
C11H20N2O2 |
![4-[[3-(1-Methylethyl)-2-oxo-5-oxazolidinyl]methoxy]benzaldehyde](/CAS/20150408/GIF/1173203-26-3.gif) |
4-[[3-(1-Methylethyl)-2-oxo-5-oxazolidinyl]methoxy]benzaldehyde |
1173203-26-3 |
C14H17NO4 |
![EMpagliflozin iMpurity 9](/) |
EMpagliflozin iMpurity 9 |
|
|
![EMpagliflozin iMpurity 14](/CAS/20211123/GIF/2137418-13-2.gif) |
EMpagliflozin iMpurity 14 |
2137418-13-2 |
C23H27ClO8 |
![ibrutinib iMpurity A](/) |
ibrutinib iMpurity A |
|
|
![Sunitinib iMpurity E](/) |
Sunitinib iMpurity E |
|
|
![Rosuvastatin EP impurity H](/CAS/20210111/GIF/1335110-44-5.gif) |
Rosuvastatin EP impurity H |
1335110-44-5 |
C22H28FN3O6S |
![Saxagliptin Impurity 4 (Deoxy Saxagliptin)](/) |
Saxagliptin Impurity 4 (Deoxy Saxagliptin) |
|
|
![Betamethasone EP Impurity D](/CAS/20180629/GIF/52619-05-3.gif) |
Betamethasone EP Impurity D |
52619-05-3 |
C25H33FO7 |
![Dihydropenicillin F Potassium Salt](/CAS/20211123/GIF/31447-86-6.gif) |
Dihydropenicillin F Potassium Salt |
31447-86-6 |
C14H23KN2O4S |
![Etoricoxib Impurity 7](/CAS/20200611/GIF/646459-39-4.gif) |
Etoricoxib Impurity 7 |
646459-39-4 |
C20H21N3O2S |
![Mupirocin Impurity D](/CAS/20180629/GIF/CB12741867.gif) |
Mupirocin Impurity D |
|
C26H44O9 |
![Phenylephrine EP Impurity D](/CAS/20180629/GIF/1367567-95-0.gif) |
Phenylephrine EP Impurity D |
1367567-95-0 |
C16H19NO2 |
![Verapamil Impurity O](/CAS/20180629/GIF/959011-16-6.gif) |
Verapamil Impurity O |
959011-16-6 |
C27H38N2O4 |
![1,1′-(イソプロピルイミノ)ビス[3-[4-(2-メトキシエチル)フェノキシ]-2-プロパノール]](/CAS/20211123/GIF/1486464-40-7.gif) |
1,1′-(イソプロピルイミノ)ビス[3-[4-(2-メトキシエチル)フェノキシ]-2-プロパノール] |
1486464-40-7 |
C27H42ClNO6 |
![4'-FLUOROCYCLOPROPANECARBOXANILIDE](/CAS/20180629/GIF/2354-89-4.gif) |
4'-FLUOROCYCLOPROPANECARBOXANILIDE |
2354-89-4 |
C10H10FNO |
![(Z)-2-(2-Aminothiazol-4-yl)-2-(1-carboxy-1-methyl)ethoxyiminoacetic acid](/CAS/GIF/102507-85-7.gif) |
(Z)-2-(2-Aminothiazol-4-yl)-2-(1-carboxy-1-methyl)ethoxyiminoacetic acid |
102507-85-7 |
C9H11N3O5S |
![Cefaclor EP IMpurity](/) |
Cefaclor EP IMpurity |
|
|
![Linagliptin Impurity F](/CAS/20180808/GIF/1673546-62-7.gif) |
Linagliptin Impurity F |
1673546-62-7 |
C27H27F3N8O3 |
![Parecoxib Impurity D](/) |
Parecoxib Impurity D |
|
|
![Parecoxib Impurity I](/) |
Parecoxib Impurity I |
|
|
![Lenvatinib Impurity d](/CAS/20180808/GIF/417717-04-5.gif) |
Lenvatinib Impurity d |
417717-04-5 |
C20H17ClN4O4 |
![4-ブロモ-3-(ヒドロキシメチル)フェノール](/CAS/GIF/2737-20-4.gif) |
4-ブロモ-3-(ヒドロキシメチル)フェノール |
2737-20-4 |
C7H7BrO2 |
![4-(4-Bromo-3-formyl-phenoxy)-benzonitrile](/CAS/GIF/906673-54-9.gif) |
4-(4-Bromo-3-formyl-phenoxy)-benzonitrile |
906673-54-9 |
C14H8BrNO2 |
![Linagliptin Impurity I](/) |
Linagliptin Impurity I |
|
|
![1H-Pyrrole-3-carbonitrile,5-(2-fluorophenyl)-1-(3-pyridinylsulfonyl)-](/CAS/20180629/GIF/1807642-39-2.gif) |
1H-Pyrrole-3-carbonitrile,5-(2-fluorophenyl)-1-(3-pyridinylsulfonyl)- |
1807642-39-2 |
C16H10FN3O2S |
![4-amino-1-[(2RS)-2-(2,4-difluorophenyl)-2-hydroxy-3(1H-
1,2,4-triazol-1-yl)propyl]-4H-1,2,4-triazolium](/CAS/20180629/GIF/749821-19-0.gif) |
4-amino-1-[(2RS)-2-(2,4-difluorophenyl)-2-hydroxy-3(1H-
1,2,4-triazol-1-yl)propyl]-4H-1,2,4-triazolium |
749821-19-0 |
C13H14F2N7O+ |
![Canagliflozin Defluoro Impurity](/) |
Canagliflozin Defluoro Impurity |
|
|
![Dapagliflozin Impurity 6](/) |
Dapagliflozin Impurity 6 |
|
|
![Imatinib Impurity 7](/CAS/20180808/GIF/581076-64-4.gif) |
Imatinib Impurity 7 |
581076-64-4 |
C8H12N4 |
![Nilotinib Impurity 1](/CAS/20210111/GIF/641571-05-3.gif) |
Nilotinib Impurity 1 |
641571-05-3 |
C28H22F3N7O |
![Riociguat Impurtiy 1](/) |
Riociguat Impurtiy 1 |
|
|
![Riociguat Impurtiy 6](/CAS/20180808/GIF/1702271-98-4.gif) |
Riociguat Impurtiy 6 |
1702271-98-4 |
C18H17FN8 |
![Brimonidine Impurity E](/CAS/20180808/GIF/168329-48-4.gif) |
Brimonidine Impurity E |
168329-48-4 |
C9H8BrN5 |
![Dapagliflozin Impurity G](/) |
Dapagliflozin Impurity G |
|
|
![Dapoxetine Impurity B](/) |
Dapoxetine Impurity B |
|
|
![Fesoterodine Diol Dimer](/CAS/20180808/GIF/1428856-45-4.gif) |
Fesoterodine Diol Dimer |
1428856-45-4 |
C44H60N2O3 |
![Gimeracil Impurity](/CAS/20180808/GIF/17902-24-8.gif) |
Gimeracil Impurity |
17902-24-8 |
C8H9ClN2O3 |
![Pramipexole Impurity H](/) |
Pramipexole Impurity H |
|
|
![Rivaroxaban Impurity H](/CAS/20200515/GIF/1807455-76-0.gif) |
Rivaroxaban Impurity H |
1807455-76-0 |
C25H24Cl2N4O6S2 |
![Vonoprazan impurity A](/) |
Vonoprazan impurity A |
|
|
![5-ethyl 3-isopropyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate](/CAS/20200119/GIF/2170716-02-4.gif) |
5-ethyl 3-isopropyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
2170716-02-4 |
C22H29ClN2O5 |
![Ibrutinib impurity D](/) |
Ibrutinib impurity D |
|
|
![Mupirocin impurity A](/CAS/20180629/GIF/CB13053659.gif) |
Mupirocin impurity A |
|
C26H44O9 |
![FG-4592 intermediate7](/CAS/20200611/GIF/1509958-19-3.gif) |
FG-4592 intermediate7 |
1509958-19-3 |
C20H20N2O4 |
![Milnacipran Impurity 13](/CAS/20211123/GIF/710339-49-4.gif) |
Milnacipran Impurity 13 |
710339-49-4 |
C12H16NO+ |
![Urapidil Impurity A](/) |
Urapidil Impurity A |
|
|
![Tofacitinib Impurity I](/) |
Tofacitinib Impurity I |
|
|
![N-(3-chloro-4-fluorophenyl)-6 ,7-dimethoxyquinazolin-4-amine](/CAS/20200515/GIF/153437-78-6.gif) |
N-(3-chloro-4-fluorophenyl)-6 ,7-dimethoxyquinazolin-4-amine |
153437-78-6 |
C16H13ClFN3O2 |
![N-[4-[2-(メチルアミノ)エトキシ]ベンジル]-3,4-ジメトキシベンズアミド](/CAS/20200515/GIF/141996-97-6.gif) |
N-[4-[2-(メチルアミノ)エトキシ]ベンジル]-3,4-ジメトキシベンズアミド |
141996-97-6 |
C19H24N2O4 |
![Mirabegron Impurity](/CAS/20180808/GIF/1796931-48-0.gif) |
Mirabegron Impurity |
1796931-48-0 |
C21H24N4O2S |
![Ibuprofen Impurity 2](/CAS/20180702/GIF/CB43359503.gif) |
Ibuprofen Impurity 2 |
|
C13H18O2 |
![Imatinib Impurity 9](/) |
Imatinib Impurity 9 |
|
|
![Isavuconazole Impurity 22](/) |
Isavuconazole Impurity 22 |
|
|
![Isavuconazole Impurity 28](/) |
Isavuconazole Impurity 28 |
|
|
![3-モノクロロトリヨードチロニン](/CAS/20211123/GIF/909279-46-5.gif) |
3-モノクロロトリヨードチロニン |
909279-46-5 |
C15H11ClI3NO4 |
![Linagliptin Impurity 42](/) |
Linagliptin Impurity 42 |
|
|
![PalBociclib Impurity 25](/) |
PalBociclib Impurity 25 |
|
|
![Posaconazole Impurity 13](/CAS/20211123/GIF/357189-98-1.gif) |
Posaconazole Impurity 13 |
357189-98-1 |
C37H40F2N8O6 |
![Posaconazole Impurity 25](/CAS/20200515/GIF/1042398-26-4.gif) |
Posaconazole Impurity 25 |
1042398-26-4 |
C16H19F2IO3 |
![Posaconazole Impurity 42](/CAS/20210111/GIF/357189-96-9.gif) |
Posaconazole Impurity 42 |
357189-96-9 |
C36H40F2N8O5 |
![Posaconazole Impurity 65](/) |
Posaconazole Impurity 65 |
|
|
![Pramipexole Dimer Impurity (Mixture of Diastereomers)](/CAS/20211123/GIF/1147937-31-2.gif) |
Pramipexole Dimer Impurity (Mixture of Diastereomers) |
1147937-31-2 |
C13H23N3S |
![Sitafloxacin Impurity 1](/) |
Sitafloxacin Impurity 1 |
|
|
![Sitagliptin Impurity 25](/) |
Sitagliptin Impurity 25 |
|
|
![sofosBuvir impurity 47](/) |
sofosBuvir impurity 47 |
|
|
![SofosBuvir Impurity 64](/) |
SofosBuvir Impurity 64 |
|
|
![Tofacitinib Impurity W](/) |
Tofacitinib Impurity W |
|
|
![Trelagliptin Impurity 21](/) |
Trelagliptin Impurity 21 |
|
|
![2-chloromethyl-4-(3-hydroxypropoxy)-3-methylpyridine](/CAS/20200119/GIF/117976-92-8.gif) |
2-chloromethyl-4-(3-hydroxypropoxy)-3-methylpyridine |
117976-92-8 |
C10H14ClNO2 |
![8-Methoxy Entecavir](/CAS/20210111/GIF/2203740-23-0.gif) |
8-Methoxy Entecavir |
2203740-23-0 |
C13H17N5O4 |
![Bortezomib Impurity 32](/CAS/20180906/GIF/1310383-72-2.gif) |
Bortezomib Impurity 32 |
1310383-72-2 |
C17H31BF3NO5 |
![Topiroxostat Impurity 14](/) |
Topiroxostat Impurity 14 |
|
|
![1-Pyrrolidinecarboxylic acid, 4-hydroxy-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4S)-](/CAS/20180529/GIF/401564-34-9.gif) |
1-Pyrrolidinecarboxylic acid, 4-hydroxy-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4S)- |
401564-34-9 |
C13H22N2O4S |
![Ampicillin Impurity B](/) |
Ampicillin Impurity B |
|
|
![Clindamycin Phosphate EP Impurity K](/) |
Clindamycin Phosphate EP Impurity K |
|
|
![7,7'-(butane-1,4-diylbis(oxy))bis(quinolin-2(1H)-one)](/CAS/20180529/GIF/2116542-19-7.gif) |
7,7'-(butane-1,4-diylbis(oxy))bis(quinolin-2(1H)-one) |
2116542-19-7 |
C22H20N2O4 |